长非编码RNA在肿瘤细胞有氧糖酵解中的调控作用

doi:10.3760/cma.j.issn.1673-422X.2019.03.008

摘要/Abstract

摘要： Long noncoding RNA (lncRNA) is a kind of RNA with a length greater than 200 nucleotides and lacks proteincoding function. Varieties of lncRNAs have been found to play major roles in the aerobic glycolysis of tumor cells, such as lncRNAp21, H19, prostate specific transcript 1 (PGCEM1) and so on. In tumor cells, lncRNA can directly regulate the ratelimiting enzyme in the glycolytic pathway, also can indirectly regulate the glycolysis by hypoxia inducible factor1α (HIF1α) or protooncogene cmyc. Further study on the mechanism of lncRNA regulating tumor cell glycolysis is expected to open up new ideas for the diagnosis and treatment of tumor diseases.

关键词: Neoplasms, Glycolysis, RNA, long noncoding

Abstract: Long noncoding RNA (lncRNA) is a kind of RNA with a length greater than 200 nucleotides and lacks proteincoding function. Varieties of lncRNAs have been found to play major roles in the aerobic glycolysis of tumor cells, such as lncRNAp21, H19, prostate specific transcript 1 (PGCEM1) and so on. In tumor cells, lncRNA can directly regulate the ratelimiting enzyme in the glycolytic pathway, also can indirectly regulate the glycolysis by hypoxia inducible factor1α (HIF1α) or protooncogene cmyc. Further study on the mechanism of lncRNA regulating tumor cell glycolysis is expected to open up new ideas for the diagnosis and treatment of tumor diseases.

Key words: Neoplasms, Glycolysis, RNA, long noncoding

钟晨怡，冒韵东. 长非编码RNA在肿瘤细胞有氧糖酵解中的调控作用[J]. 国际肿瘤学杂志, 2019, 46(3): 170-173.

Zhong Chenyi, Mao Yundong. Regulating effect of lncRNA on aerobic glycolysis in tumor cells[J]. Journal of International Oncology, 2019, 46(3): 170-173.

参考文献

［1］ SalcianoSilca A, LoboAlves SC, Almeida RC, et al. Besides pathology: long noncoding RNA in cell and tissue homeostasis［J］. Noncoding RNA, 2018, 4(1): pii: E3. DOI: 10.3390/ncrna4010003. ［2］ Kang W, Zheng Q, Lei J, et al. Prognostic value of long noncoding RNAs in patients with gastrointestinal cancer: a systematic review and metaanalysis［J］. Dis Markers, 2018, 2018: 5340894. DOI: 10.1155/2018/5340894. ［3］ Yu L, Chen X, Sun X, et al. The glycolytic switch in tumors: how many players are involved?［J］. J Cancer, 2017, 8(17): 34303440. DOI: 10.7150/jca.21125. ［4］ Hofmann P. Cancer and exercise: Warburg hypothesis, tumour metabolism and highintensity anaerobic exercise［J］. Sports (Basel), 2018, 6(1): pii: E10. DOI: 10.3390/sports6010010. ［5］ Zhao M, Fan J, Liu Y, et al. Oncogenic role of the TP53induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NFκB pathway modulation［J］. Int J Oncol, 2016, 48(2): 756764. DOI: 10.3892/ijo.2015.3297. ［6］ Panisova E, Kery M, Kopacek J, et al. Enhanced metabolism as a common feature of cancer plasticity［J］. Neoplasma, 2016, 63(6): 836845. DOI: 10.4149/neo_2016_602. ［7］ Ye Y, He X, Lu F, et al. A lincRNAp21/miR181 family feedback loop regulates microglial activation during systemic LPS and MPTP induced neuroinflammation［J］. Cell Death Dis, 2018, 9(8): 803. DOI: 10.1038/s4141901808215. ［8］ Tang SS, Zheng BY, Xiong XD. LincRNAp21: implications in human diseases［J］. Int J Mol Sci, 2015, 16(8): 1873218740. DOI: 10.3390/ijms160818732. ［9］ Shen Y, Liu Y, Sun T, et al. LincRNAp21 knockdown enhances radiosensitivity of hypoxic tumor cells by reducing autophagy through HIF1/Akt/mTOR/P70S6K pathway［J］. Exp Cell Res, 2017, 358(2): 188198. DOI: 10.1016/j.yexcr.2017.06.016. ［10］ Peng F, Wang JH, Fan WJ, et al. Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia［J］. Oncogene, 2018, 37(8): 1119. DOI: 10.1038/onc.2017.407. ［11］ Zhang S, Li Z, Zhang L, et al. MEF2activated long noncoding RNA PCGEM1 promotes cell proliferation in hormonerefractory prostate cancer through downregulation of miR148a［J］. Mol Med Rep, 2018, 18(1): 202208. DOI: 10.3892/mmr.2018.8977. ［12］ ArriagaCanon C, De La Rosa aVelázquez IA, GonzálezBarrios R, et al. The use of long noncoding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer［J］. Oncotarget, 2018, 9(29): 2087220890. DOI: 10.18632/oncotarget.25038. ［13］ Aird J, Baird AM, Lim MCJ, et al. Carcinogenesis in prostate cancer: the role of long noncoding RNAs［J］. Noncoding RNA Res, 2018, 3(1): 2938. DOI: 10.1016/j.ncrna.2018.01.001. ［14］ Kim T, Croce CM. Long noncoding RNAs: undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis［J］. Cancer Lett, 2018, 417: 8995. DOI: 10.1016/j.canlet.2017.12.033. ［15］ Szafron LM, Balcerak A, Grzybowska EA, et al. The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients［J］. Oncotarget, 2015, 6(41): 4389743910. DOI: 10.18632/oncotarget.6016. ［16］ Esposti DD, HernandezVargas H, Voegele C, et al. Identification of novel long noncoding RNAs deregulated in hepatocellular carcinoma using RNAsequencing［J］. Oncotarget, 2016, 7(22): 3186231877. DOI: 10.18632/oncotarget.7364. ［17］ Kong Y, Hsieh CH, Alonso LC. ANRIL: a lncRNA at the CDKN2A/B locus with roles in cancer and metabolic disease［J］. Front Endocrinol (Lausanne), 2018, 9: 405. DOI: 10.3389/fendo.2018.00405. ［18］ Zou ZW, Ma C, Medoro L, et al. LncRNA ANRIL is upregulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing sidepopulation stemlike cancer cells［J］. Oncotarget, 2016, 7(38): 6174161754. DOI: 10.18632/oncotarget.11437. ［19］ Lin A, Li C, Xing Z, et al. The LINKA lncRNA activates normoxic HIF1alpha signalling in triplenegative breast cancer［J］. Nat Cell Biol, 2016, 18(2): 213224. DOI: 10.1038/ncb3295. ［20］ Heneberg P. Redox regulation of hexokinases［J］. Antioxid Redox Signal, 2019, 30(3): 415442. DOI: 10.1089/ars.2017.7255. ［21］ Zhang Y, Liu Y, Xu X. Knockdown of LncRNAUCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA125a/hexokinase 2 pathway［J］. J Cell Biochem, 2018, 119(7): 62966308. DOI: 10.1002/jcb.26899. ［22］ Ma J, Fan Y, Feng T, et al. HOTAIR regulates HK2 expression by binding endogenous miR125 and miR143 in oesophageal squamous cell carcinoma progression［J］. Oncotarget, 2017, 8(49): 8641086422. DOI: 10.18632/oncotarget.21195. ［23］ Song J, Wu X, Liu F, et al. Long noncoding RNA PVT1 promotes glycolysis and tumor progression by regulating miR497/HK2 axis in osteosarcoma［J］. Biochem Biophys Res Commun, 2017, 490(2): 217224. DOI: 10.1016/j.bbrc.2017.06.024. ［24］ Xiao ZD, Zhuang L, Gan B. Long noncoding RNAs in cancer metabolism［J］. Bioessays, 2016, 38(10): 991996. DOI: 10.1002/bies.201600110. ［25］ Fan C, Tang Y, Wang J, et al. Role of long noncoding RNAs in glucose metabolism in cancer［J］. Mol Cancer, 2017, 16(1): 130. DOI: 10.1186/s1294301706993. ［26］ Luo F, Liu X, Ling M, et al. The lncRNA MALAT1, acting through HIF1α stabilization, enhances arseniteinduced glycolysis in human hepatic L02 cells［J］. Biochim Biophys Acta, 2016, 1862(9): 16851695. DOI: 10.1016/j.bbadis.2016.06.004. ［27］ Zhang P, Cao L, Fan P, et al. LncRNAMIF, a cmycactivated long noncoding RNA, suppresses glycolysis by promoting FBXW7mediated cmyc degradation［J］. EMBO Rep, 2016, 17(8): 12041220. DOI: 10.15252/embr.201642067. ［28］ Xiao C, Wu C, Hu HZ. LncRNA UCA1 promotes epithelialmesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/betacatenin signaling pathway［J］. Eur Rev Med Pharmacol Sci, 2016, 20(13): 28192924. ［29］ Rrpaimoole R, Lee J, Haemmerle M, et al. Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis［J］. Cell Rep, 2015, 13(11): 23952402. DOI: 10.1016/j.celrep.2015.11.047.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[3]	龚艳, 陈洪雷. 微RNA调控卵巢癌顺铂耐药的机制研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 186-190.
[4]	刘博翰, 黄俊星. 液体活检技术在食管鳞状细胞癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 105-108.
[5]	柳洋, 蒋路路, 管凯文, 周岳阳, 康小红. linc01410在恶性肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2023, 50(9): 540-543.
[6]	崔曼莉, 路宁, 朱琳, 李茜, 张明鑫. 基于高通量测序数据分析食管鳞状细胞癌circRNA的研究[J]. 国际肿瘤学杂志, 2023, 50(6): 328-335.
[7]	全祯豪, 徐飞鹏, 黄哲, 黄先进, 陈日红, 孙开裕, 胡旭, 林琳. 沉默lncRNA FTX通过miR-22-3p/NLRP3炎症体通路抑制胃癌细胞增殖[J]. 国际肿瘤学杂志, 2023, 50(4): 202-207.
[8]	拜莹, 李琦, 李亚芹, 赵卫红. E2F1与lncRNA在恶性肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2023, 50(3): 164-168.
[9]	闫学敏, 武霄勇, 张佳谊, 文锦旭, 王跃欣. SPRY4-IT1与乳腺癌[J]. 国际肿瘤学杂志, 2023, 50(10): 627-630.
[10]	马小平, 常君丽, 孙星媛, 杨燕萍. 长非编码RNA调控骨肉瘤耐药机制的研究进展[J]. 国际肿瘤学杂志, 2023, 50(1): 51-54.
[11]	周仁邦, 张仲传, 许志远, 朱勋兵. miR-219a-5p通过负调控HMGA2抑制骨肉瘤U2OS细胞增殖、侵袭和迁移[J]. 国际肿瘤学杂志, 2022, 49(4): 193-198.
[12]	张俊鹏, 于燕燕, 李宝生. lncRNA、circRNA调控食管鳞状细胞癌放化疗敏感性的作用机制[J]. 国际肿瘤学杂志, 2022, 49(3): 185-189.
[13]	金嘉会, 陈存海, 马学真. 放射相关miRNA在乳腺癌放疗中的作用[J]. 国际肿瘤学杂志, 2022, 49(12): 735-738.
[14]	向光宇, 李家贺, 季刚, 郭欣, 卢强. 单细胞RNA测序技术在食管鳞状细胞癌辅助诊疗中的应用[J]. 国际肿瘤学杂志, 2022, 49(12): 745-748.
[15]	井文君, 赵文文, 冯青青, 赵文飞, 赵丽丽, 张雪, 魏红梅. miR-34家族用于胃癌治疗的分子基础及临床前景[J]. 国际肿瘤学杂志, 2022, 49(11): 681-686.